Dyax Reviews

Rating Trends
Recommend to a friend
Approve of CEO
Dyax President, CEO, and Director Gustav A. Christensen
Gustav A. Christensen
3 Ratings
  • Dyax is a good place to work.

    • Work/Life Balance
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Scientist I in Cambridge, MA
    Current Employee - Scientist I in Cambridge, MA
    No opinion of CEO


    The company's culture is very good. Every year employees make a lot donation to charities.


    Layoff happened since 3 years ago.

Dyax Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Analytical Scientist Interview

    Anonymous Interview Candidate in Burlington, MA
    No Offer
    Positive Experience
    Average Interview


    I applied through a recruiter. The process took 2+ months. I interviewed at Dyax (Burlington, MA) in March 2015.


    I applied through a recruiter. A couple of weeks later, I had a 30 minute phone screening with the hiring manager. She was very nice and seemed very clear about the set of skills and experience required for the position.. She made a comment about my "good communication skills", adding that she was glad to see that would not be an issue [?]. [My guess is that she was trying to make a point about the importance of communicating effectively when dealing with contractors]. About a month later, I was invited to visit the company and meet the team. I have to say I was quite impressed at their knowledge and insight but also at their friendliness. The overall atmosphere seemed very cooperative, respectful and collegial. It looks like a great place to work with a lot of potential for professional growth. The HR representative was also extremely pleasant and professional. Unfortunately, I was not their first choice.

    Interview Questions

Dyax Awards & Accolades

Something missing? Add an award
Top Places to Work Globe 100 , Boston Globe, 2008

Additional Info

Unlock Profile
Website www.dyax.com
Headquarters Burlington, MA
Size 51 to 200 Employees
Founded 1989
Type Company - Public (DYAX)
Industry Biotech & Pharmaceuticals
Revenue $50 to $100 million (USD) per year

Dyax is arming the war against disease. The biopharmaceutical company develops drugs from its proprietary technology that rapidly identifies proteins, peptides, and antibodies it can use to treat disease, with a primarily focus on oncology and inflammation remedies. Dyax's first commercial drug, Kalbitor (DX-88), has been approved in the US to treat hereditary angioedema (HAE, a condition causing tissue swelling) in patients 16 and older. DX-88 is being investigated for additional indications. The company has other product candidates in discovery and development ... More

Work at Dyax? Share Your Experiences


Click to Rate